Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease

Annals of Hematology

Volumn 90, Issue 2, 2011, Pages 145-150

  Tripathi, Avnish ^a   Jerrell, Jeanette M ^c   Stallworth, James R ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Adenotonsillectomy; Cost reductions; Sickle cell disease; Vaso occlusive pain episodes

Indexed keywords

HYDROXYUREA; PENICILLIN G;

ACUTE CHEST SYNDROME; ADENOTONSILLECTOMY; ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHILD; CHILD HEALTH CARE; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SICKLE CELL ANEMIA; SLEEP APNEA SYNDROME; TONSILLITIS; TRANSIENT ISCHEMIC ATTACK; VEIN OCCLUSION; VEIN PAIN;

ACUTE CHEST SYNDROME; ADENOIDECTOMY; ADOLESCENT; ANEMIA, SICKLE CELL; BRAIN ISCHEMIA; CHILD; COST-BENEFIT ANALYSIS; ETHNIC GROUPS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MEDICAID; PAIN; RECURRENCE; SLEEP APNEA, OBSTRUCTIVE; SOUTH CAROLINA; TONSILLECTOMY; TREATMENT OUTCOME; UNITED STATES;

EID: 78751575588     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1048-4     Document Type: Article

References (24)

1. th edition. WB Saunders Elsevier, Philadelphia, PA. Available at http://www.mdconsult.com/das/book/body/143898456-9/853444084/1608/1067. html#4-u1.0-B978-1-4160-2450-7..50464-3 - cesec19-8724. Accessed 17 June 2009
2. RL Duke JP Scott JA Panepinto VA Flanary 2006 Perioperative management of sickle cell disease children undergoing adenotonsillectomy Otolaryngol Head Neck Surg 134 370 373 10.1016/j.otohns.2005.11.001 16500429
3. TL Kauf TD Coates L Huazhi N Mody-Patel AG Hartzema 2009 The cost of health care for children and adults with sickle cell disease Am J Hematol 84 323 327 10.1002/ajh.21408 19358302
4. YA Wali H al Okbi R al Abri 2003 A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy Pediatr Hematol Oncol 20 7 13 12687748
5. J Buck SC Davies 2005 Surgery in sickle cell disease Hematol Oncol Clin North Am 19 897 902 10.1016/j.hoc.2005.07.004 16214650
6. JS Kemp 1996 Obstructive sleep apnea and sickle cell disease (comment) J Pediatr Hematol Oncol 18 104 105 1:STN:280:DyaK283gvFOgsw%3D%3D 10.1097/00043426-199605000-00002 8846119
7. MM Heeney RE Ware 2008 Hydroxyurea for children with sickle cell disease Pediatr Clin N Am 55 483 501 10.1016/j.pcl.2008.02.003
8. SO Ajulo 1994 The significance of recurrent tonsillitis in sickle cell disease Clin Otolaryngol Allied Sci 19 230 233 1:STN:280:DyaK2M%2FgvVejsg%3D%3D 10.1111/j.1365-2273.1994.tb01220.x 7923845
9. GT Ijaduola OO Akinyanju 1987 Chronic tonsillitis, tonsillectomy and sickle cell crises J Laryngol Otol 101 467 470 1:STN:280:DyaL2s3isVGhtQ%3D%3D 3585161
10. JD Sidman TL Fry 1988 Exacerbation of sickle cell disease by obstructive sleep apnea Arch Otolaryngol Head Neck Surg 114 916 917 1:STN:280: DyaL1c3mvFantg%3D%3D 3390338
11. BR Maddern HT Reed K Ohene-Frempong RC Beckerman 1989 Obstructive sleep apnea syndrome in sickle cell disease Ann Otol Rhinol Laryngol 98 174 178 1:STN:280:DyaL1M7msFWitA%3D%3D 2923395
12. CS Derkay G Bray GJ Milmoe KM Grundfast 1991 Adenotonsillectomy in children with sickle cell disease South Med J 84 205 208 1:STN:280: DyaK3M7hvVSkuw%3D%3D 1990454
13. DJ Halvorson V McKie K McKie PE Ashmore ES Porubsky 1997 Sickle cell disease and tonsillectomy. Preoperative management and postoperative complications Arch Otolaryngol Head Neck Surg 123 689 692 1:STN:280: DyaK2sznvFOrtQ%3D%3D 9236586
14. S Dodd A Bassi K Bodger P Williamson 2006 A comparison of multivariable regression models to analyze cost data J Eval Clin Pract 12 76 86 10.1111/j.1365-2753.2006.00610.x 16422782
15. HJ Lipscomb JM Dement B Silverstein W Cameron JE Glazner 2009 Who is paying the bills? Health care costs for musculoskeletal back disorders, Washington State union carpenters, 1989-2003 J Occup Environ Med 51 1185 1192 10.1097/JOM.0b013e3181b68d0a 19749603
16. MH Steinberg 2005 Predicting clinical severity in sickle cell anaemia Br J Haematol 129 465 481 1:CAS:528:DC%2BD2MXls1aktbY%3D 10.1111/j.1365-2141.2005. 05411.x 15877729
17. M Mvundura D Amendah PL Kavanagh PG Sprinz SD Grosse 2009 Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States Pediatr Blood Cancer 53 642 646 10.1002/pbc.22069 19492318
18. C Haywood Jr MC Beach S Lanzkron JJ Strouse R Wilson H Park C Witkop EB Bass JB Segal 2009 A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease J Natl Med Assoc 101 1022 1033 19860302
19. GD Stevens L Shi 2003 Racial and ethnic disparities in the primary care experiences of children: a review of the literature Med Care Res Rev 60 3 30 10.1177/1077558702250229 12674018
20. OW Brawley LJ Cornelius LR Edwards VN Gamble BL Green C Inturrisi AH James D Laraque M Medez CJ Montoya BH Poolock L Robinson AP Scholnik M Schori 2008 National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease Ann Intern Med 148 932 938 18458271
21. SM Shankar PG Arbogast E Mitchel WO Cooper WC Wang MR Griffin 2005 Medical care utilization and mortality in sickle cell disease: a population-based study Am J Hematol 80 262 270 10.1002/ajh.20485 16315251
22. SD Grosse SL Boulet DD Amendah, et al. 2010 Administrative data sets and health services research on hemoglobinopathies: a review of the literature Am J Prev Med 38 4 Suppl S557 S567 10.1016/j.amepre.2009.12.015 20331958
23. S Hennessy CE Leonard CP Freeman R Deo C Newcomb SE Kimmel BL Strom WB Bilker 2010 Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data Pharmacoepidemiol Drug Saf 19 6 555 562 10.1002/pds.1869 19844945
24. LB Chibnik EM Massarotti KH Costenbader 2010 Identification and validation of lupus nephritis cases using administrative data Lupus 19 6 741 743 1:STN:280:DC%2BC3c3nsFGmug%3D%3D 10.1177/0961203309356289 20179167